Results
eNauka >
Results >
Trilaciclib improves overall survival when given with gemcitabine/carboplatin (GC) in patients with metastatic triple negative breast cancer (mTNBC) in a randomized phase II trial
| Title: | Trilaciclib improves overall survival when given with gemcitabine/carboplatin (GC) in patients with metastatic triple negative breast cancer (mTNBC) in a randomized phase II trial | Authors: | O'Shaughnessy, J; ...; Popovic, Lazar S   ; ...; Milenkovic, Dusan M; ...; (broj, koautora 17) |
Issue Date: | 2019 | Publication: | ANNALS OF ONCOLOGY | ISSN: | 0923-7534 Annals of Oncology Search Idenfier |
Type: | Conference Paper | Collation: | vol. 30 str. 860-+ | WoS-ID: | 000491295500146 | URI: | https://enauka.gov.rs/handle/123456789/821442 | Project: | G1 Therapeutics, Inc. | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | Mp. category will be shown later |
1
WEB OF SCIENCETM
Google ScholarTM
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.